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Abstract
This paper describes unsuccessful attempts to induce a nocturnally-periodic infection with simian
Loa in a human volunteer (the author of this paper) by means of 1. Transplanting adult simian Loa
worms from a wild drill (Mandrillus leucophaeus) to man; and 2. Infecting the same volunteer by sub-
cutaneous inoculation with infective larvae of simian Loa from a laboratory-bred, experimentally
infected Chrysops silacea.
Findings
In the mid 1950s, one of the main lines of research fol-
lowed by the Helminthiasis Research Unit (HRU), at
Kumba in the then British Cameroons was to establish the
relationship between human infections with Loa loa and
the highly similar Loa parasites which were found in sev-
eral species of local monkey, especially in the drill (Man-
drillus leucophaeus) but also, less frequently, in several
long-tailed monkey species, Cercopithecus nictitans martini,
C. mona mona and C. preussi.
Observations on 109 young drills (found to be free from
natural  Loa  infection after a quarantine period of 6–8
months in screened cages), which were experimentally
infected by transplantation of live adult simian Loa worms
extracted from wild drills shot in the local forests, revealed
that the parasites exhibited a nocturnal microfilarial peri-
odicity with microfilariae (mf) that were significantly
longer than those of human L. loa.
By contrast, drills which had been infected by inoculation
of infective larvae from the day-biting Chrysops silacea or
C. dimidiata, that had been experimentally infected 10
days previously by feeding on the blood of Loa-infected
human volunteers, demonstrated diurnally-periodic
microfilarial infections, whose parasites (both adult
worms and mf) were of shorter length than the normal
wild monkey parasites [1].
Further studies on the biting habits of local Chrysops spe-
cies revealed that in nature the diurnally periodic human
Loa loa was transmitted among humans by the day-biting
species C. silacea and C. dimidiata, whereas the nocturnally
periodic simian parasite was being transmitted among
monkeys by two forest-canopy-dwelling species, C. langi
and C. centurionis, both of which bite in the forest canopy
at night and are presumed to feed mainly on sleeping
monkeys [2].
No naturally-acquired diurnally periodic microfilarial
infection was seen in 21 wild drills, the periodicities of
whose adult worms were examined by transplantation
into uninfected animals; despite the fact that male and
female worms of human and simian Loa were quite capa-
ble, when transplanted together under experimental con-
ditions into uninfected drills, of inter-breeding and
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producing microfilariae of intermediate dimensions and
periodicity [3]. (This is not to say that under natural con-
ditions diurnally-periodic worms of human Loa are never
transmitted to monkeys, but such events, if they do occur,
appear to be rare).
Later, Belgian workers in the Mayumbe District in the
south-western part of the Democratic Republic of the
Congo (DRC), commented on the local human Loa infec-
tions in that area being particularly liable to give rise to
cases of Loa-encephalopathy after treatment with diethyl-
carbamazine citrate (DEC). They also noted that out of
547 patients from this area, whose blood films were
examined both by day and night, 197 showed Loa mf only
by day, 322 showed them by day and by night; and 16
showed mf only at night. Although the latter cases, with a
complete reversal of the normal periodicity, showed only
light microfilarial loads (12 cases with 1–5 mf per exami-
nation, and 4 cases with 6–9 mf per examination), among
those persons who showed Loa mf by day and by night, 62
showed microfilarial concentrations that were nearly as
high by night as by day and 10 showed more mf by night
than by day (two of them showing 500 – 1,000 mf by
night as compared with 300 – 500 mf by day) [4-6]. As
some of the cases of loiasis from Mayumbe were abnor-
mal in displaying a primarily nocturnal periodicity of the
microfilariae, it is possible that the local strain of Loa
responsible for them may be closely related to the simian
parasite.
Recently in the Republic of Cameroon, cases of Loa-
encephalopathy have been reported following mass treat-
ment with ivermectin by the African Programme for
Onchocerciasis Control (APOC) in areas where loiasis is
co-endemic with onchocerciasis [7-11]. A remarkable
clustering of many of these cases was found in the Lékié
Division, a forest and forest/savannah mosaic area some
80 km from the capital, Yaoundé. So far, the reason for
this clustering has not become apparent but the occur-
rence of these cases of Loa-encephalopathy has had a del-
eterious effect on the popularity of the APOC campaign in
that area [12]. Furthermore, at the end of 2003 in the May-
umbe area of the DRC, some 100,000 persons were
treated with a standard single dose of ivermectin distrib-
uted as part of the activities of APOC, and 41 cases of seri-
ous adverse reactions (SAEs) were reported, of which 14
were fatal despite appropriate management of the
patients. This is an incidence rate even higher than that
reported in Lékié Division of Cameroon and has led to the
establishment of a commission to examine the matter (Dr
B. Thylefors, personal communication).
The patho-biological reasons for the occurrence of Loa-
encephalopathy following treatment with DEC or with
ivermectin, mainly seen in patients heavily infected with
Loa microfilariae, are not well understood, and co-factors
may exist that account for the fact that some patients do
not develop SAEs despite having high Loa microfilarae-
mia. Experimental work by Dr Samuel Wanji using an ani-
mal model is currently trying to reproduce heavy
microfilaraemic infections of human L. loa in experimen-
tally infected monkeys (mainly Mandrillus  spp) and to
investigate the biochemical and pathological changes that
accompany the development of any Loa-encephalopathy
following ivermectin treatment.
In the original work at the HRU, Kumba, where it was rel-
atively easy to infect young drills experimentally (either
by inoculation of infective larvae or by transplantation of
adult worms) with either the nocturnally-periodic simian
Loa parasite or with the diurnally-periodic human para-
site, it was obviously far more difficult to determine
whether the nocturnally-periodic simian parasite could be
transferred to man. Nevertheless, at that time, before the
discovery of the potentially deadly viruses such as Ebola,
Marburg and HIV that are believed to originate from mon-
keys, attempts to infect a human (the author) experimen-
tally with a simian strain of the Loa  parasite were
undertaken. Today, such experiments would not only be
viewed as unethical but also as potentially life-threaten-
ing.
In 1954 and 1955, the author (who at that time had no
signs or symptoms of loiasis and who was not taking any
medication, apart from 200 mg proguanil (Paludrine)
daily as a prophylactic for malaria), took part in two such
experiments, which have not been previously published
but are relevant in the light of the localised occurrence of
Loa-encephalopathy in some individuals following treat-
ment with ivermectin. These attempts at experimental
infection of a human being with simian Loa are as follows:
In July 1954, a large male drill, which had been shot in the
forest near Kumba some 3–4 hours previously, was
brought into the laboratory by the Unit's hunter. It was
immediately dissected and a total of seven male and fif-
teen female mature simian Loa worms, all alive, undam-
aged and motile, were collected from the subcutaneous
and intermuscular tissues. The worms were placed in ster-
ile normal saline solution, along with a small quantity of
merthiolate, in the same manner that had been used pre-
viously to transplant adult simian Loa worms successfully
into other monkeys. Two and a half hours later, 12 of
these live, motile, adult female worms and five males were
inserted, under local anaesthesia, into the upper, anterior
part of the right thigh of the author by the Medical Officer-
in-Charge of the Kumba Medical Field Unit. After making
a 3-inch, longitudinal incision through the skin and the
superficial fascia, the simian Loa worms were inserted,
some into the sub-cutaneous tissue and others under theFilaria Journal 2004, 3:5 http://www.filariajournal.com/content/3/1/5
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deep fascia of the rectus femoris muscle. The fascial layers
were then sewn up, the skin closed with nylon sutures,
and intramuscular penicillin was given to counteract
infection.
Over the ensuing week the transplant area became consid-
erably swollen and painful over an area of approximately
6–8 × 5–6 inches and over the following month it itched
frequently. Day and night blood films (50 cu. mm) were
taken once a week over a period of six months, and there-
after fortnightly for the next six months, but none of them
detected any microfilariae. No Loa  worm(s) appeared
under the skin or crossing the eye, nor did any Loa mf
appear in the peripheral blood over the next 46 years. (It
is possible that all the worms died fairly soon after being
inserted, or it may be that they remained alive but failed
to produce a detectable microfilarial infection).
Eighteen months after the transplant, the author also
injected himself subcutaneously in the left thigh with 35
live, motile, infective larvae of simian Loa, which had
been dissected out in normal saline from a laboratory-
bred female Chrysops silacea that had taken a blood-meal
10 days previously from a captive drill infected with the
nocturnally-periodic simian strain of Loa. Previous exper-
imental work with monkeys had shown that this method
of infection was more effective than trying to induce a
Chrysops containing infective larvae of Loa to feed on, and
thus transmit infective Loa larvae to, an uninfected per-
son. There was a slight reddening and itching of the skin
in the area around the injection site over the following
week but otherwise no papular eruption or other reaction
developed. No Loa  microfilariae were detected in the
peripheral blood by day or by night over the ensuing eight
years; nor, over the same period was any skin reaction
seen that could have been attributed to the death of L3 or
subsequent stages of L. loa dying in or under the skin, as
were reported subsequently when infective larvae of L. loa
from the bite of an experimentally-infected Chrysops sila-
cea were subsequently killed by dosage with diethylcar-
bamazine citrate (DEC) used as a chemoprophylactic
[13].
Both these attempts failed to infect a healthy human vol-
unteer with the nocturnally-periodic simian strain of Loa.
Obviously the failure to infect a single individual must be
interpreted with caution. Nevertheless these observations
are worth recording especially now that research is in
progress to try and ascertain:
1. The factors leading to the localised occurrence of Loa-
encephalopathy in certain areas of central Africa, where
ivermectin is now being used currently for the control of
onchocerciasis, or where in the past it has occurred fol-
lowing treatment with diethylcarbamazine; and
2. The biochemical and histological changes that may be
associated with a Loa-encephalopathy if it can be induced
in drills heavily infected with Loa mf when treated with
ivermectin.
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